ATE148631T1 - Therapeutische agens bei hornhautverletzungen - Google Patents

Therapeutische agens bei hornhautverletzungen

Info

Publication number
ATE148631T1
ATE148631T1 AT91919156T AT91919156T ATE148631T1 AT E148631 T1 ATE148631 T1 AT E148631T1 AT 91919156 T AT91919156 T AT 91919156T AT 91919156 T AT91919156 T AT 91919156T AT E148631 T1 ATE148631 T1 AT E148631T1
Authority
AT
Austria
Prior art keywords
therapeutic agent
corneal
activity
lactoperoxidase
growth
Prior art date
Application number
AT91919156T
Other languages
English (en)
Inventor
Shiro - Higashiyamacho Mita
Mitsushi - - Kitaouchic Hikida
Michel Francois Degre
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE148631T1 publication Critical patent/ATE148631T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/832Milk; colostrum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91919156T 1990-11-13 1991-11-08 Therapeutische agens bei hornhautverletzungen ATE148631T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30803690 1990-11-13

Publications (1)

Publication Number Publication Date
ATE148631T1 true ATE148631T1 (de) 1997-02-15

Family

ID=17976118

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91919156T ATE148631T1 (de) 1990-11-13 1991-11-08 Therapeutische agens bei hornhautverletzungen

Country Status (9)

Country Link
US (1) US5561109A (de)
EP (1) EP0579830B1 (de)
JP (1) JP2840795B2 (de)
AT (1) ATE148631T1 (de)
DE (1) DE69124627T2 (de)
DK (1) DK0579830T3 (de)
ES (1) ES2096663T3 (de)
GR (1) GR3023080T3 (de)
WO (1) WO1992008477A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07196529A (ja) * 1993-12-29 1995-08-01 Morinaga Milk Ind Co Ltd 創傷治癒剤、化粧料および養毛剤
JP3118584B2 (ja) * 1995-05-08 2000-12-18 参天製薬株式会社 術後乱視予防剤
JPH1149698A (ja) 1997-07-31 1999-02-23 Santen Pharmaceut Co Ltd 安定性を向上させたラクトフェリンの水性製剤
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
US20030203839A1 (en) * 1999-10-29 2003-10-30 Kruzel Marian L. Immune enhancing composition containing lactoferrin
US6613741B2 (en) * 1999-10-29 2003-09-02 Ferro Dynamics, Inc. Method for treating aseptic SIRS in humans and other animals
AU2001236114A1 (en) * 2000-05-29 2001-12-11 Wakamoto Pharmaceutical Co., Ltd. Remedies for corneal injuries
SE0200667D0 (sv) * 2002-03-05 2002-03-05 A & Science Invest Ab Novel use of cytokine inhibitors
EP2298338B1 (de) * 2002-09-16 2012-08-22 Agennix Incorporated Lactoferrin-Zusammenfassungen und Verfahren zur Behandlung von Hautwunden
WO2004052281A2 (en) * 2002-12-06 2004-06-24 Agennix Incorporated Oral lactoferrin in the treatment of sepsis
WO2004054608A2 (en) * 2002-12-12 2004-07-01 Agennix Incorporated Lactoferrin in the reduction of pain
CA2489208C (en) 2003-02-24 2012-11-06 Morinaga Milk Industry Co., Ltd. Interleukin-6 suppressive agent
CN100480378C (zh) 2004-02-17 2009-04-22 森永乳业株式会社 生产乳过氧化物酶的方法
US20070059300A1 (en) * 2005-09-12 2007-03-15 Zoltan Laboratories Llc Compounds and compositions to control abnormal cell growth
EP1942928A2 (de) * 2005-10-31 2008-07-16 Essential Skincare, LLC Proteinzusammensetzung zur förderung der wundheilung und hautregeneration
JP2013530990A (ja) * 2010-07-01 2013-08-01 ブライエン ホールデン ビジョン インスティテュート 創傷治療に係るラクトフェリンの配列、組成物、及び方法
KR20210038636A (ko) 2018-07-27 2021-04-07 존슨 앤드 존슨 서지컬 비전, 인코포레이티드 눈 치료용 조성물 및 방법
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460135A1 (fr) * 1979-07-02 1981-01-23 Liotet Serge Composition a usage externe a base de colostrum
LU85479A1 (fr) * 1984-07-25 1986-02-12 Oleofina Sa Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer
US4745100A (en) * 1985-05-14 1988-05-17 Eye Research Institute Of Retina Foundation Stimulation of tear secretion
FR2600250B1 (fr) * 1986-06-23 1989-11-24 Bio Serae Procede pour conditionner une composition antibacterienne et composition antibacterienne conditionnee
JPH0248534A (ja) * 1988-07-28 1990-02-19 Bio Serae Sa:Soc 抗菌組成物の配合方法及び配合された抗菌組成物

Also Published As

Publication number Publication date
WO1992008477A1 (fr) 1992-05-29
EP0579830A1 (de) 1994-01-26
EP0579830A4 (de) 1993-10-06
GR3023080T3 (en) 1997-07-30
ES2096663T3 (es) 1997-03-16
DE69124627T2 (de) 1997-06-12
JP2840795B2 (ja) 1998-12-24
DE69124627D1 (de) 1997-03-20
EP0579830B1 (de) 1997-02-05
DK0579830T3 (da) 1997-08-18
US5561109A (en) 1996-10-01

Similar Documents

Publication Publication Date Title
ATE148631T1 (de) Therapeutische agens bei hornhautverletzungen
ATE361093T1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
ATE142693T1 (de) Herstellung des vaskulären endothelialen zellwachstumsfaktors
ATE274918T1 (de) Albumin als aktiven bestandteil zur behandlung von bindehaut- und hornhautverletzungen und von trockenen augen
GR3007107T3 (de)
EP0376251A3 (en) An anticoagulant substance obtained from urine
BR9007115A (pt) Novo trombolitico
DE68924006D1 (de) Pharmazeutische Zusammensetzungen mit Eierschalenbestandteilen und ihre Herstellung und Verwendung.
KR930702019A (ko) 피부.각막 질환 치료제
DE69100607D1 (de) Zusammensetzung zur Herstellung von künstlicher Milch für Kälber und daraus hergestellte künstliche Milch für Kälber.
ES2073391T3 (es) Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre.
EP0373771A3 (de) Neue pharmazeutische Anwendungen von Cystatinen
DE3784628D1 (de) Dermale behandlung von wurmerkrankungen der katze mit praziquantel.
ATE224727T1 (de) Faktor xiii zur behandlung von hautwunden
DE69228031D1 (de) Ch0ndromodulin-II Protein
ATE132877T1 (de) Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung
IT1216096B (it) L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
FR2661091B1 (fr) Utilisation de l'hexetidine ou de ses derives ou sels pour la preparation d'une composition pharmaceutique a usage ophtalmologique.
ATE218869T1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
ES2009146A6 (es) Procedimiento de obtencion de una solucion aminopeptidica de origen animal por procesos enzimaticos
DE69833317D1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
ITMI910114V0 (it) Struttura di calza ortopedica in particolare per la cura e la prevenzione del valgismo dell'alluce
TH44140A (th) " รีคอมบิเนนท์ โอเบส (โอบี) โปรทีน "
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.
ATE79759T1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee